Modification of Doses of Efavirenz According to Its Blood Concentration in HIV Patients
Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
This is a study on the utility of the modification of doses of efavirenz guided by its plasma
concentration (therapeutic drug monitoring) in HIV-infected patients initiating treatment
with Sustiva.
Phase:
Phase 4
Details
Lead Sponsor:
Dr . BONAVENTURA CLOTET Germans Trias i Pujol Hospital